Prakash C. Neupane, MBBS

Professional Background

I am a medical oncologist who is focused on head and neck and thoracic oncology. I am also the director of the hematology-oncology fellowship and co-chair of the head and neck disease working group. The area of research is clinical research in head and neck oncology.

I started my career as a clinician and several years of general hematology-oncology practice in a small community hospital.

• MBBS, Medical School, equivalent to US MD , Tribhuvan University, Kathmandu, Nepal
• Residency, Internal Medicine, St. Barnabas Hospital-Affiliated with NY Hospital/Cornell , Bronx, NY
• Clinical Fellowship, Hematology and Medical Oncology, Louisiana State University Health Sciences Center- Shreveport, Shreveport, LA

• Kansas Medical license , Kansas State Board of Healing Arts
• Missouri Board of Healing arts
• Prakash Neupane, American Board of Hematology
• Prakash Neupane, American Board of Medical Oncology

• American Society of Clinical Oncology, ITE Task Force , Member, 2019 - 2022
• American Society of Clinical Oncology, ASCO, Member, 1998 - Present

---

Research

Overview

I am actively working as head and neck cancer disease working group co-chair. Several clinical trials are open in the disease area including new innovative cell therapy trials in head and neck cancers. I am interested to work on innovative trials immune altering clinical research. I am open to any collaboration with any translational researcher and industry for such innovative clinical research.

• Mohyuddin, Ghulam Rehman , Dominick, Anthony , Black, Travis ., Jonathan , Hoffman, Marc , Male, Heather, Byrd, Kenneth, McClune, Brian , Eck, Leigh , Neupane, Prakash., C. 2020. A Critical Appraisal and Targeted Intervention of the Oncology Experience in an Internal Medicine Residency. Journal of Cancer Education. https://rdcu.be/b4mps
• Huang, Chao., H, Wick, Jo, Sittampalam, Gurusingham., Sitta, Victor Sanjit Nirmalanandhan, Victor., Sanjit, Ganti, Apar., Kishor , Neupaane, Prakash., C, Williamson, Stephen., K, Godwin, Andrew., K, Schmitt, Sarah, Smart, Nora., J, Spencer, Sarah, Van Veldhuizen, Peter., J. 2014. A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer. FRONTIERS IN ONCOLOGY, 14 (4), 271
• Burke, Ellen, Rockey, Michelle, Grauer, Dennis, Henry, Dave, Neupane, Prakash., Chandra. 2017. Assessment of cetuximab-induced infusion reactions and administration rechallenge at an academic medical center. MEDICAL ONCOLOGY, 34 (4)
• Lominska, Chris , Estes, Christopher ., Fleighton, Neupane, Prakash, Shnayder, Yelizaveta, Tennapel, Mindi, O’Neil, Maura ., F. 2017. CASTLE thyroid tumor: A case report and literature review. Frontiers in Oncology, 7, 207
• Adkins, D, Ley, J, Neupane, Prakash, Worden, F, Sacco, AG, Palka, K, Grilley-Olson, JE, Maggiore, R, Salama, NN, Trinkaus , K, Van Tine, BA, Steuer, CE, Saba, NF, Oppelt, P. 2019. Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.. The Lancet Oncololgy, 20 (9), 1295
• Ferris, Robert., L., Saba, Nabil., F., Gitlitz, Barbara., J., Haddad, Robert, Sukari, Ammar, Neupane, Prakash, Morris, John., C., Misiukiewicz, Krzysztof, Bauman, Julie., E., Fenton, Moon, Jimeno, Antonio, Adkins, Douglas., R., Schneider, Charles., J., Sacco, Assuntina., G., Shirai, Keisuke, Bowles, Daniel., W., Gibson, Michael, Nwizu, Tobenna, Gottardo, Raphael, Manjarrez, Kristi., L., Dietsch, Gregory., N., Bryan, James., Kyle, Hershberg, Robert., M., Cohen, Ezra E. W.. 2018. Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck The Active8 Randomized Clinical Trial. JAMA Oncology, 4 (11), 1583-1588
• Dulal, Soniya, Paudel, Bishnu., D, Neupane, Prakash, Shah, Arati, Acharya, Bibek, Paudel, Bishesh., S, Silpakar, Ramila, Wood, Lori. 2019. Efficacy of haloperidol versus olanzapine for control of chemotherapy induced nausea and vomiting. Journal of Global Oncology (5), 1-6
• Narveson, Lisa, Kathol, Emily, Rockey, Michelle, Henry, David, Grauer, Dennis, Neupane, Prakash., Chandra. 2016. Evaluation of weekly paclitaxel, carboplatin, and cetuximab in head and neck cancer patients with incurable disease. MEDICAL ONCOLOGY, 33 (10)
• Dakhil, Christopher, Wick, Jo, Loknath Kumar, Anup Kasi , Satyan, Megha., Teeka, Neupane, Prakash., Chandra. 2014. Extrapulmonary small cell carcinoma: the University of Kansas experience and review of literature. MEDICAL ONCOLOGY, 31 (10), 187
• Burtness, Barbara, Rischin, Danny, Greil, Richard, Soulieres, Denis, Tahara, Makoto, de Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash, Bratland, Ase, Fuereder, Thorsten, Hughes, Brett., G., Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Ishak, Wan Zamaniah Wan, Ge, Joy, Swaby, Ramona, Gumuscu, Burak, Harrington, Kevin. 2020. Efficacy of first-line (1L) pembrolizumab by PD-L1 combined positive score < 1, 1-19, and >= 20 in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): KEYNOTE-048 subgroup analysis. CANCER RESEARCH, 80 (16)